Comprehensive Financial Health Assessment: B2BE LIMITED

1. Financial Health Score: F

Explanation: The patient is in critical condition. B2BE LIMITED suffers from severe chronic insolvency, meaning its liabilities vastly exceed its assets. The company is entirely dependent on life support in the form of creditor forbearance—specifically, trade creditors who are not demanding immediate payment. Without this external support, the company would face immediate terminal failure.

2. Key Vital Signs

Based on the latest filed accounts for the year ending 31 December 2024:

• Net Liabilities (Blood Pressure): -£2,589,628 The company’s total assets (£492,567) are drastically lower than its total liabilities (£3,082,195). This is the financial equivalent of critically low blood pressure, indicating the business is technically insolvent on a balance sheet basis.
• Current Ratio (Pulse/Oxygen Levels): 0.14 Calculated as Current Assets (£457,112) divided by Current Liabilities (£3,082,195). A healthy pulse is typically between 1.5 and 2.0. At 0.14, the company has only 14p of short-term assets for every £1 of short-term debt. The patient cannot breathe independently without creditor intervention.
• Cash Reserves (Hydration): £162,638 While cash levels have remained relatively stable compared to 2023 (£167,630), this represents a dangerously low liquidity position relative to the massive debts owed.
• Trade Creditors (Life Support): £2,751,924 Trade creditors represent the vast majority (over 89%) of total liabilities. This unusual reliance suggests the company is likely part of a wider corporate group, utilizing intercompany trade balances to remain operational.
• Shareholder Deficit (Patient History): Worsening The accumulated deficit has grown steadily over the past decade, worsening from -£677,935 in 2015 to -£2,589,628 in 2024. The underlying disease is progressive.

3. Diagnosis

Chronic Balance Sheet Insolvency with Acute Creditor Dependency

The financial data reveals a business that is fundamentally hollow on paper. The patient is suffering from a severe equity deficit, meaning years of accumulated losses have entirely consumed the share capital and created a deep financial chasm.

However, the director’s going concern note provides the crucial context for why this patient is still breathing: the principal creditors are providing ongoing support. In a typical standalone business, owing £2.75M in trade creditors with only £162k in cash and £267k in trade debtors would result in immediate administration. The fact that B2BE LIMITED continues to trade suggests these "trade creditors" are likely related group companies or a patient parent entity funding the operations. The business is essentially operating on a financial ventilator.

The increase in tangible fixed assets (from £17,188 to £35,455) and the growth in trade debtors (from £197,361 to £267,192) suggest that the business is still actively undertaking commercial activities and investing in equipment, rather than winding down. The disease is chronic, but the patient is still mobile.

4. Recommendations

To stabilize the patient and improve long-term financial wellness, the following interventions are required:

1. Equity Transfusion (Capital Injection): The £2.59M negative equity must be addressed. The parent company or sole director needs to formally inject equity capital to reduce the technical insolvency. This could be done by capitalizing existing intercompany loans (converting debt to equity) or through fresh cash investment.
2. Debt Restructuring (Surgical Intervention): The reliance on trade creditors needs to be formally structured. If these are group liabilities, they should be formally reclassified as long-term intercompany loans rather than current trade creditors. This would dramatically improve the current ratio and relieve the short-term liquidity pressure.
3. Working Capital Improvement (Physical Therapy): The company must focus on accelerating trade debtor collections (£267k is currently owed). Tightening credit terms with clients will generate healthier cash flow and reduce reliance on creditor life support.
4. Profitability Focus (Vitamin Boost): While the profit and loss account isn't fully detailed here, the persistent growth of the accumulated deficit indicates ongoing trading losses. The core business model must be evaluated to ensure operations are genuinely profitable at the gross margin level before group overheads are applied.